Top Markets
Coin of the day
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
Clasificación en acciones #26668
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
Precio por acción
$5.54
Última sincronización: 2024-09-18
Capitalización bursátil
$38.76M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Alimera Sciences, Inc. (ALIM)

Categoría

EPS de Alimera Sciences, Inc. (ALIM)
EPS a fecha de June 2024 TTM: $-0.28
Según los últimos informes financieros y el precio de las acciones de Alimera Sciences, Inc., el EPS actual de la empresa (TTM) es $-0.28. Al final del año 2022, la empresa tenía un EPS de $-2.59 un aumento con respecto a al EPS de 2021, que fue de $-0.66.
Historial de EPS de Alimera Sciences, Inc. desde 2006 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $-0.28 -64.56%
2023 $-0.79 -69.50%
2022 $-2.59 292.42%
2021 $-0.66 -36.54%
2020 $-1.04 -52.51%
2019 $-2.19 -158.40%
2018 $3.75 -176.06%
2017 $-4.93 -47.66%
2016 $-9.42 -8.90%
2015 $-10.34 -22.43%
2014 $-13.33 -45.14%
2013 $-24.30 158.24%
2012 $-9.41 -12.63%
2011 $-10.77 61.95%
2010 $-6.65 -98.48%
2009 $-437.12 -23.24%
2008 $-569.46 977.30%
2007 $-52.86 -56.02%
2006 $-120.18 0.00%
EPS de empresas similares o competidoras